Integra - Model Metrics - Custom Software Development
Integra IT provides customized software development services in response to each client’s necessities and challenges in healthcare and clinical research. Our dedicated development team allows us to create, set up, and launch robust and customized tools in record time. We have comprehensive experience in data management and processing at a country scale, successfully operating nationwide and multicountry-wide support.
- Clinical trial follow-up from the beginning through the end
- Registration of indicators, times, changes, and comparative analysis
- Dynamic and reliable clinical studies record
- Compare national or regional indicators with international ones
- High-end technology with 100% serverless architecture and data safety standards
- Users
- Sponsors
- CROs
- IRB (Institutional Review Boards)
- Sites
- Trials
- Reports
- Amendments
- Affordable (accessible) for small and medium size Sites, CROs, and Sponsors
- Real-time data for data-driven decisions
- Faster start-up studies
- Interoperability (integrations between own and third-party systems)
- Validated and GCP-compliant
- On-demand scalable architecture (per solutions, modules, and features)
- Expertise in low and middle-income countries
- Vaccine-exclusive features available
- Around 70% of our clinical research experts are Latin American professionals with global experience
The Metrics software is a tailor-made tool that enables the user to record and control clinical trial development for countries, local authorities, and associations, aiming for time management in a unified database. Check trial status, establish key indicators for effective decision-making and optimize resources and efforts strategically to make the local clinical trials field more competitive and efficient.
Currently, the Metrics solution is being used by the most important pharmaceutical, I&D, and research organization in Colombia (AFIDRO), contributing to clinical research development and improving tracking trial progress. Likewise, having this kind of tool helps to attract investment and find new ways to promote clinical research initiatives in middle and emerging markets.